The global burden of disease due to benign gynecological conditions: A call to action
International Journal of Gynecology & Obstetrics · 2024-03 · 164 (3) · 1151-1159
DOI: 10.1002/ijgo.15211 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Gynecology & Obstetrics, online erschienen am 21.11.2023. Verfasst von Dileep Wijeratne und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynaecology, Leeds Teaching Hospitals, Leeds, UK. Hauptthemen laut MEDLINE: Global Burden of Disease, Persons with Disabilities. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Royal College of Obstetricians and Gynaecologists.
Abstract (Originalsprache)
Objective
Focusing on low‐ and middle‐income countries (LMICs), this article uses data from the Global Burden of Disease (GBD) database to highlight the burden of morbidity due to benign gynecological conditions (BGCs).
Methods
We analyzed 2019 morbidity data for all BGCs, measured as years lost to disability (YLDs). Disease burden was calculated for individual conditions, BGCs overall, and percentages of overall disease burden from all conditions. The same data extraction was performed for malaria, tuberculosis, and HIV/AIDS for comparison. The data were subcategorized by age and World Bank income level.
Results
BGCs are major causes of disease morbidity worldwide. For women aged 15 years and over in high‐income countries (HICs), 3 588 157 YLDs (3.94% of all YLDs) were due to BGC. In LMICs, 18 242 989 YLDs (5.35% of all YLDs) were due to BGCs. The highest burden of BGCs is seen during the reproductive years where conditions driven or exacerbated by reproductive hormones are the major causes of morbidity. In LMICs, for women aged 15–49, 14 574 100 YLDs (7.75% of all YLDs) were due to BGCs, declining to 3 152 313 YLDs (3.04%) in women aged 50–69 and 529 399 YLDs (1.06%) in women age 70+.
Conclusion
These data demonstrate a huge burden of morbidity due to BGCs. There is an urgent need for international stakeholders to prioritize the treatment and prevention of BGCs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Obstetrics and Gynaecology, Leeds Teaching Hospitals, Leeds, UK.
- School of Medicine, Cardiff University, Cardiff, UK.
- Centre for Women's Global Health, Royal College of Obstetricians and Gynaecologists, London, UK.
- Royal College of Obstetricians and Gynaecologists, London, UK.
ORCID-Profile: Dileep Wijeratne, Joanna F E Gibson, Alison Fiander, Ranee Thakar
Förderung
- Royal College of Obstetricians and Gynaecologists
Zitieren
APA
Wijeratne, D., Gibson, J. F. E., Fiander, A., Rafii-Tabar, E., & Thakar, R. (2024). The global burden of disease due to benign gynecological conditions: A call to action. International Journal of Gynecology & Obstetrics, 164(3), 1151-1159. https://doi.org/10.1002/ijgo.15211
Vancouver
Wijeratne D, Gibson JFE, Fiander A, Rafii-Tabar E, Thakar R. The global burden of disease due to benign gynecological conditions: A call to action. International Journal of Gynecology & Obstetrics. 2024;164(3):1151-1159. doi:10.1002/ijgo.15211
BibTeX
@article{Wijeratne2024,
author = {Wijeratne, Dileep and Gibson, Joanna F E and Fiander, Alison and Rafii-Tabar, Elizabeth and Thakar, Ranee},
title = {The global burden of disease due to benign gynecological conditions: A call to action},
journal = {International Journal of Gynecology & Obstetrics},
year = {2024},
volume = {164},
number = {3},
pages = {1151--1159},
doi = {10.1002/ijgo.15211}
}
EUVIMED